Colorado Blood Cancer Institute
- Research works
- 74 ▼ 10% vs 2013–17
- Citations
- 1.9k 25.4 per fractional work
- Top-10% rate
- 21.2% record average 16.5%
- Open access
- 40% world 28%
Not ranked overall: Colorado Blood Cancer Institute is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.9×. Every wedge is a field page.
- Immunology and Microbiology 9.9×
- Medicine 3.8×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Pharmacology, Toxicology and Pharmaceutics 1.8×
- Chemistry 0.6×
- Health Professions 0.3×
- Neuroscience 0.2×
- Social Sciences 0.1×
- Materials Science 0.1×
- Mathematics 0.1×
- Psychology 0.1×
- Engineering 0.0×
- Computer Science 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Colorado Blood Cancer Institute?
Ranked on the composite score, Jeffrey Matous and Michael Tees lead among researchers whose main affiliation is Colorado Blood Cancer Institute.
- 1 Jeffrey Matous United States · #228,162 worldwide 118 citations · 28 works
- 2 Michael Tees United States · #1,260,945 worldwide 16 citations · 19 works
Which keywords describe research at Colorado Blood Cancer Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Lymphoma, Cancer Immunotherapy, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Rituximab, Prognostic Factors and Minimal Residual Disease.
- Cancer Cachexia
- Therapeutic Targets
- Chronic Lymphocytic Leukemia
- Classification
- Prognosis
- Proteasome Inhibitors
- International Myeloma Working Group
- Minimal Residual Disease
- Prognostic Factors
- CAR T Cells
- Cancer Immunotherapy
- Lymphoma
- Immunotherapy
- Chimeric Antigen Receptor
- Rituximab
- Diagnosis Criteria
- PET Imaging
- Staging System
- Monoclonal Antibodies
- Molecular Profiling
- Genomic Aberrations
- Inflammation
- Sarcopenia
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 23 words, with their numbers
- Lymphoma6▲ 164×2 topics
- Cancer Immunotherapy5▲ 147×3 topics
- Immunotherapy5▲ 31×6 topics
- CAR T Cells5▲ 281×1 topic
- Chimeric Antigen Receptor5▲ 281×1 topic
- Prognostic Factors2▲ 25×5 topics
- Rituximab2▲ 73×3 topics
- Minimal Residual Disease2▲ 139×2 topics
- Diagnosis Criteria2▲ 208×1 topic
- International Myeloma Working Group2▲ 208×1 topic
- PET Imaging2▲ 44×4 topics
- Proteasome Inhibitors2▲ 106×2 topics
- Staging System2▲ 123×2 topics
- Prognosis2▲ 20×6 topics
- Monoclonal Antibodies1▲ 70×2 topics
- Classification1▲ 13×1 topic
- Molecular Profiling1▲ 58×1 topic
- Chronic Lymphocytic Leukemia1▲ 115×1 topic
- Genomic Aberrations1▲ 115×1 topic
- Therapeutic Targets1▲ 34×2 topics
- Inflammation1▲ 2.3×6 topics
- Cancer Cachexia1▲ 50×1 topic
- Sarcopenia1▲ 50×1 topic
Which research topics does Colorado Blood Cancer Institute publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment and Chronic Lymphocytic Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 5 works
- 2 Multiple Myeloma Research and Treatments Hematology 2 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 4 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 5 Nutrition and Health in Aging Physiology 1 works
- 6 Protein Degradation and Inhibitors Molecular Biology 1 works
- 7 Biosimilars and Bioanalytical Methods Immunology 1 works
- 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 9 Acute Myeloid Leukemia Research Hematology 1 works
- 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Colorado Blood Cancer Institute's research output changed?
Output in 2018–2022 was 10% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Denver
- University of Colorado Denver
- University of Denver
- National Jewish Health
- Denver Health Medical Center
- Presbyterian St. Luke's Medical Center
- Denver Federal Center
- Metropolitan State University of Denver
- Denver School of Nursing
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.